Verastem to Host Conference Call on March 3rd to Discuss Fourth Quarter and Full-Year 2015 Financial Results and Recent Highlights

BOSTON--()--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the Company will host a conference call and webcast on Thursday, March 3, 2016 at 8:30 a.m. Eastern Time to discuss corporate updates and financial results for the fourth quarter year ended December 31, 2015.

The call can be accessed by dialing (877) 341-5660 (U.S. and Canada) or (315) 625-3226 (international), and entering passcode 53106888. To access the live webcast, or the subsequent archived recording, please use either the following link: or visit the investors section of the Verastem website at

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is a biopharmaceutical company focused on discovering and developing drugs to improve outcomes for patients with cancer. Our product candidates utilize a multi-faceted approach to treat cancer by reducing cancer stem cells, enhancing anti-tumor immunity, and modulating the local tumor microenvironment. Our most advanced clinical product candidates are the Focal Adhesion Kinase inhibitors, VS-6063 and VS-4718, and the dual PI3K/mTOR inhibitor, VS-5584. For more information, please visit


Verastem, Inc.
Brian Sullivan, 781-292-4214

Recent Stories

RSS feed for Verastem, Inc.

Verastem, Inc.